TD Private Client Wealth’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Buy |
20,129
+1,362
| +7% | +$95.2K | 0.03% | 297 |
|
|
2025
Q1 | $1.38M | Buy |
18,767
+1,959
| +12% | +$144K | 0.04% | 286 |
|
|
2024
Q4 | $1.1M | Buy |
16,808
+6,201
| +58% | +$406K | 0.03% | 337 |
|
|
2024
Q3 | $826K | Sell |
10,607
-1,401
| -12% | -$109K | 0.02% | 387 |
|
|
2024
Q2 | $937K | Sell |
12,008
-1,384
| -10% | -$108K | 0.03% | 355 |
|
|
2024
Q1 | $907K | Sell |
13,392
-19
| -0.1% | -$1.29K | 0.03% | 361 |
|
|
2023
Q4 | $903K | Buy |
13,411
+979
| +8% | +$65.9K | 0.03% | 342 |
|
|
2023
Q3 | $842K | Sell |
12,432
-3,241
| -21% | -$219K | 0.04% | 336 |
|
|
2023
Q2 | $1.12M | Sell |
15,673
-1,684
| -10% | -$121K | 0.05% | 312 |
|
|
2023
Q1 | $1.2M | Sell |
17,357
-8,663
| -33% | -$601K | 0.05% | 297 |
|
|
2022
Q4 | $1.76M | Buy |
26,020
+101
| +0.4% | +$6.85K | 0.08% | 237 |
|
|
2022
Q3 | $1.42M | Sell |
25,919
-1,626
| -6% | -$89.2K | 0.07% | 250 |
|
|
2022
Q2 | $1.82M | Sell |
27,545
-1,331
| -5% | -$87.9K | 0.09% | 223 |
|
|
2022
Q1 | $1.92M | Buy |
28,876
+900
| +3% | +$59.7K | 0.08% | 242 |
|
|
2021
Q4 | $1.63M | Buy |
27,976
+3,502
| +14% | +$204K | 0.07% | 271 |
|
|
2021
Q3 | $1.47M | Buy |
24,474
+1,332
| +6% | +$80K | 0.06% | 282 |
|
|
2021
Q2 | $1.39M | Buy |
23,142
+3,409
| +17% | +$204K | 0.06% | 290 |
|
|
2021
Q1 | $981K | Buy |
19,733
+246
| +1% | +$12.2K | 0.05% | 316 |
|
|
2020
Q4 | $974K | Buy |
19,487
+402
| +2% | +$20.1K | 0.05% | 305 |
|
|
2020
Q3 | $1.05M | Sell |
19,085
-8,983
| -32% | -$492K | 0.06% | 285 |
|
|
2020
Q2 | $1.48M | Buy |
28,068
+1,321
| +5% | +$69.9K | 0.09% | 223 |
|
|
2020
Q1 | $1.19M | Buy |
26,747
+4,322
| +19% | +$193K | 0.09% | 201 |
|
|
2019
Q4 | $1.12M | Buy |
+22,425
| New | +$1.12M | 0.07% | 257 |
|